サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1713705

迷走神経刺激の世界市場レポート 2025年

Vagus Nerve Stimulation Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
迷走神経刺激の世界市場レポート 2025年
出版日: 2025年04月23日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

迷走神経刺激市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は14.6％で、17億6,000万米ドルに成長します。予測期間の成長は、治療抵抗性うつ病の有病率の増加、低侵襲神経外科手術の採用の増加、研究開発（R&D）イニシアチブの高まり、ヘルスケアインフラの改善、神経疾患の有病率と発生率の増加に起因しています。予測期間における主な動向には、技術の進歩、製品設計の革新、ロボット支援移植、電気刺激装置、刺激技術の革新などがあります。

神経疾患の有病率の上昇は、今後数年間の迷走神経刺激市場の成長を促進すると予想されます。神経疾患とは、脳、脊髄、神経に影響を及ぼし、その結果、運動、感覚、認知、全体的な機能性に問題が生じる状態のことです。これらの障害の原因は様々で、多くの場合、遺伝的、環境的、ライフスタイル的要因の組み合わせが関与しています。さらに、頭部外傷や脊髄損傷などの身体的損傷も、神経学的問題につながることがあります。迷走神経刺激は、脳の活動や神経伝達物質のレベルを調整することによってこれらの障害を管理し、てんかん、うつ病、特定のタイプの片頭痛などの症状に関連する症状を緩和するのに役立ちます。例えば、2024年9月、オーストラリアの政府機関であるAustralian Institute of Health and Welfareは、2023年には約41万1,100人のオーストラリア人が認知症を患っていると推定しており、2058年にはこの数が2倍以上になると予測しています。このように、神経疾患の有病率の増加が迷走神経刺激市場の成長を後押ししています。

迷走神経刺激市場の主なプレーヤーは、植え込み型パルスジェネレータ（IPG）のような先進的な製品を開発し、慢性疾患に対する長期的で調節可能な標的治療を提供しています。植え込み型パルス発生器（IPG）は、慢性疼痛や神経障害などの症状を治療するために電気パルスを供給する皮下に植え込まれる装置です。例えば、2023年2月、英国に本拠を置く医療機器会社LivaNova Plcは、薬剤耐性てんかんを対象とした迷走神経刺激（VNS）療法に特化したIPGであるSenTiva DUOを発表しました。この装置により、旧型のデュアルピンシステムを使用している患者は、リードを交換することなくアップグレードすることができ、カスタマイズ可能な自動デリバリーによる高度なVNS療法を提供することができます。センティバDUOは、てんかん発作の制御を強化し、より良い治療のアドヒアランスをサポートすることで、これらの疾患の管理に大きな進歩をもたらします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界迷走神経刺激PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の迷走神経刺激市場：成長率分析
  • 世界の迷走神経刺激市場の実績：規模と成長, 2019-2024
  • 世界の迷走神経刺激市場の予測：規模と成長, 2024-2029, 2034F
  • 世界迷走神経刺激総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の迷走神経刺激市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 埋め込み型迷走神経刺激デバイス
  • 外部迷走神経刺激デバイス
  • 世界の迷走神経刺激市場バイオマテリアル、実績と予測, 2019-2024, 2024-2029F, 2034F
  • メタリック
  • セラミックス
  • ポリマー
  • 世界の迷走神経刺激市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • てんかん
  • うつ
  • 片頭痛
  • 世界の迷走神経刺激市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 神経科クリニック
  • 外来手術センター
  • 研究センター
  • 世界の迷走神経刺激市場埋め込み型迷走神経刺激デバイスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • パルスジェネレータ
  • リードと電極
  • 充電式埋め込み型デバイス
  • 非充電式埋め込み型機器
  • 世界の迷走神経刺激市場外部迷走神経刺激デバイスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経皮的迷走神経刺激デバイス
  • ウェアラブルVNSデバイス
  • ポータブル外部刺激装置
  • 家庭用VNSデバイス

第7章 地域別・国別分析

  • 世界の迷走神経刺激市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の迷走神経刺激市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 迷走神経刺激市場：競合情勢
  • 迷走神経刺激市場：企業プロファイル
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • NeuroTek Inc.
  • Neurospace Inc.
  • ReShape Lifesciences Inc.
  • electroCore Inc.
  • Adriakaim Inc.
  • Soterix Medical Inc.
  • Nexstim PLC
  • Cleveland Medical Devices Inc.
  • MicroTransponder Inc.
  • Parasym Ltd.
  • Neuvana LLC
  • NeuroSigma Inc.
  • Evren Technologies Inc.
  • Integrative Health Technologies Inc.
  • Aucta Technologies Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 迷走神経刺激市場2029：新たな機会を提供する国
  • 迷走神経刺激市場2029：新たな機会を提供するセグメント
  • 迷走神経刺激市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33607

Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve, a major nerve extending from the brainstem to the abdomen. This treatment affects various bodily functions, including heart rate, digestion, and mood regulation. It is primarily used to manage conditions such as epilepsy, treatment-resistant depression, and other neurological disorders.

The main products for vagus nerve stimulation include implantable VNS devices and external VNS devices. An implantable VNS device is surgically placed in the body, typically in the neck, to deliver electrical impulses to the vagus nerve. It is designed using various biomaterials, such as metals, ceramics, and polymers, and is used for treating epilepsy, depression, and migraines. These devices are utilized in several settings, including hospitals, neurology clinics, ambulatory surgical centers, and research institutions.

The vagus nerve stimulation market research report is one of a series of new reports from The Business Research Company that provides vagus nerve stimulation market statistics, including vagus nerve stimulation industry global market size, regional shares, competitors with a vagus nerve stimulation market share, detailed vagus nerve stimulation market segments, market trends and opportunities, and any further data you may need to thrive in the vagus nerve stimulation industry. This vagus nerve stimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vagus nerve stimulation market size has grown rapidly in recent years. It will grow from $0.89 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to rising geriatric population, prevalence of depression, increasing awareness and acceptance of alternative therapies, growing prevalence of epilepsy, and increasing incidence of chronic diseases.

The vagus nerve stimulation market size is expected to see rapid growth in the next few years. It will grow to $1.76 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to the growing prevalence of treatment-resistant depression, rising adoption of minimally invasive neurosurgical procedures, rising research and development (R&D) initiatives, improving healthcare infrastructure, and increasing prevalence and incidence of neurological disorders. Major trends in the forecast period include technological advancements, innovations in product design, robot-assisted implantation, electrical stimulation devices, and innovating stimulation techniques.

The rising prevalence of neurological disorders is expected to drive the growth of the vagus nerve stimulation market in the coming years. Neurological disorders are conditions that impact the brain, spinal cord, or nerves, resulting in issues with movement, sensation, cognition, or overall functionality. The causes of these disorders are varied, often involving a combination of genetic, environmental, and lifestyle factors. Moreover, physical injuries, such as head trauma and spinal cord injuries, can also lead to neurological issues. Vagus nerve stimulation is utilized to manage these disorders by modulating brain activity and neurotransmitter levels, which helps alleviate symptoms associated with conditions such as epilepsy, depression, and specific types of migraines. For instance, in September 2024, the Australian Institute of Health and Welfare, a government agency in Australia, estimated that approximately 411,100 Australians were living with dementia in 2023, with projections indicating that this number will more than double by 2058. Thus, the increasing prevalence of neurological disorders is fueling the growth of the vagus nerve stimulation market.

Key players in the vagus nerve stimulation market are developing advanced products such as implantable pulse generators (IPGs) to provide long-term, adjustable, and targeted therapy for chronic conditions. An implantable pulse generator (IPG) is a device implanted under the skin that delivers electrical pulses to treat conditions such as chronic pain or neurological disorders. For example, in February 2023, LivaNova Plc, a UK-based medical device company, introduced the SenTiva DUO, a specialized IPG for vagus nerve stimulation (VNS) therapy aimed at drug-resistant epilepsy. This device allows patients with older dual-pin systems to upgrade without lead revisions, offering advanced VNS therapy with customizable and automatic delivery. The SenTiva DUO enhances seizure control and supports better treatment adherence, marking a significant advancement in managing these conditions.

In June 2023, SCREEN Holdings Co. Ltd., a semiconductor company based in Japan, acquired shares in Adriakaim Inc. for an undisclosed amount. Following this acquisition, SCREEN plans to work with Adriakaim to accelerate the commercialization of its vagus nerve stimulation devices. SCREEN will also continue to address various needs within the medical field, contributing to solutions for societal issues. Adriakaim Inc. is a Japanese manufacturer specializing in vagus nerve stimulation devices.

Major companies operating in the vagus nerve stimulation market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Dignity Health, LivaNova LLC, NeuroTek Inc., Neurospace Inc., ReShape Lifesciences Inc., electroCore Inc., Adriakaim Inc., Soterix Medical Inc., Nexstim PLC, Cleveland Medical Devices Inc., MicroTransponder Inc., Parasym Ltd., Neuvana LLC, NeuroSigma Inc., Evren Technologies Inc., Integrative Health Technologies Inc., Aucta Technologies Inc

North America was the largest region in the vagus nerve stimulation market in 2023. The regions covered in the vagus nerve stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vagus nerve stimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vagus nerve stimulation market consists of sales of non-invasive VNS devices, stimulation generators, lead wires and electrodes, rechargeable VNS devices and wearable VNS patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vagus Nerve Stimulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vagus nerve stimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vagus nerve stimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vagus nerve stimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Implantable Vagus Nerve Stimulation Device; External Vagus Nerve Stimulation Device
  • 2) By Biomaterial: Metallic; Ceramics; Polymeric
  • 3) By Application: Epilepsy; Depression; Migraine
  • 4) By End-Use: Hospitals; Neurology Clinics; Ambulatory Surgical Centers; Research Centers
  • Subsegments:
  • 1) By Implantable Vagus Nerve Stimulation Device: Pulse Generators; Leads and Electrodes; Rechargeable Implantable Devices; Non-Rechargeable Implantable Devices
  • 2) By External Vagus Nerve Stimulation Device: Transcutaneous Vagus Nerve Stimulation Devices; Wearable VNS Devices; Portable External Stimulators; Home-use VNS Devices
  • Companies Mentioned: Medtronic PLC; Stryker Corporation; Boston Scientific Corporation; Dignity Health; LivaNova LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vagus Nerve Stimulation Market Characteristics

3. Vagus Nerve Stimulation Market Trends And Strategies

4. Vagus Nerve Stimulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vagus Nerve Stimulation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vagus Nerve Stimulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vagus Nerve Stimulation Market Growth Rate Analysis
  • 5.4. Global Vagus Nerve Stimulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vagus Nerve Stimulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vagus Nerve Stimulation Total Addressable Market (TAM)

6. Vagus Nerve Stimulation Market Segmentation

  • 6.1. Global Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Vagus Nerve Stimulation Device
  • External Vagus Nerve Stimulation Device
  • 6.2. Global Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic
  • Ceramics
  • Polymeric
  • 6.3. Global Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epilepsy
  • Depression
  • Migraine
  • 6.4. Global Vagus Nerve Stimulation Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Research Centers
  • 6.5. Global Vagus Nerve Stimulation Market, Sub-Segmentation Of Implantable Vagus Nerve Stimulation Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulse Generators
  • Leads and Electrodes
  • Rechargeable Implantable Devices
  • Non-Rechargeable Implantable Devices
  • 6.6. Global Vagus Nerve Stimulation Market, Sub-Segmentation Of External Vagus Nerve Stimulation Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Vagus Nerve Stimulation Devices
  • Wearable VNS Devices
  • Portable External Stimulators
  • Home-use VNS Devices

7. Vagus Nerve Stimulation Market Regional And Country Analysis

  • 7.1. Global Vagus Nerve Stimulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vagus Nerve Stimulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vagus Nerve Stimulation Market

  • 8.1. Asia-Pacific Vagus Nerve Stimulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vagus Nerve Stimulation Market

  • 9.1. China Vagus Nerve Stimulation Market Overview
  • 9.2. China Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vagus Nerve Stimulation Market

  • 10.1. India Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vagus Nerve Stimulation Market

  • 11.1. Japan Vagus Nerve Stimulation Market Overview
  • 11.2. Japan Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vagus Nerve Stimulation Market

  • 12.1. Australia Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vagus Nerve Stimulation Market

  • 13.1. Indonesia Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vagus Nerve Stimulation Market

  • 14.1. South Korea Vagus Nerve Stimulation Market Overview
  • 14.2. South Korea Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vagus Nerve Stimulation Market

  • 15.1. Western Europe Vagus Nerve Stimulation Market Overview
  • 15.2. Western Europe Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vagus Nerve Stimulation Market

  • 16.1. UK Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vagus Nerve Stimulation Market

  • 17.1. Germany Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vagus Nerve Stimulation Market

  • 18.1. France Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vagus Nerve Stimulation Market

  • 19.1. Italy Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vagus Nerve Stimulation Market

  • 20.1. Spain Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vagus Nerve Stimulation Market

  • 21.1. Eastern Europe Vagus Nerve Stimulation Market Overview
  • 21.2. Eastern Europe Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vagus Nerve Stimulation Market

  • 22.1. Russia Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vagus Nerve Stimulation Market

  • 23.1. North America Vagus Nerve Stimulation Market Overview
  • 23.2. North America Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vagus Nerve Stimulation Market

  • 24.1. USA Vagus Nerve Stimulation Market Overview
  • 24.2. USA Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vagus Nerve Stimulation Market

  • 25.1. Canada Vagus Nerve Stimulation Market Overview
  • 25.2. Canada Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vagus Nerve Stimulation Market

  • 26.1. South America Vagus Nerve Stimulation Market Overview
  • 26.2. South America Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vagus Nerve Stimulation Market

  • 27.1. Brazil Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vagus Nerve Stimulation Market

  • 28.1. Middle East Vagus Nerve Stimulation Market Overview
  • 28.2. Middle East Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vagus Nerve Stimulation Market

  • 29.1. Africa Vagus Nerve Stimulation Market Overview
  • 29.2. Africa Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vagus Nerve Stimulation Market Competitive Landscape And Company Profiles

  • 30.1. Vagus Nerve Stimulation Market Competitive Landscape
  • 30.2. Vagus Nerve Stimulation Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LivaNova LLC Overview, Products and Services, Strategy and Financial Analysis

31. Vagus Nerve Stimulation Market Other Major And Innovative Companies

  • 31.1. NeuroTek Inc.
  • 31.2. Neurospace Inc.
  • 31.3. ReShape Lifesciences Inc.
  • 31.4. electroCore Inc.
  • 31.5. Adriakaim Inc.
  • 31.6. Soterix Medical Inc.
  • 31.7. Nexstim PLC
  • 31.8. Cleveland Medical Devices Inc.
  • 31.9. MicroTransponder Inc.
  • 31.10. Parasym Ltd.
  • 31.11. Neuvana LLC
  • 31.12. NeuroSigma Inc.
  • 31.13. Evren Technologies Inc.
  • 31.14. Integrative Health Technologies Inc.
  • 31.15. Aucta Technologies Inc

32. Global Vagus Nerve Stimulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vagus Nerve Stimulation Market

34. Recent Developments In The Vagus Nerve Stimulation Market

35. Vagus Nerve Stimulation Market High Potential Countries, Segments and Strategies

  • 35.1 Vagus Nerve Stimulation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vagus Nerve Stimulation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vagus Nerve Stimulation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33607_Vagus_Nerve_Stimulation_GMR_2025